Jackson Square Capital, LLC Novartis Ag Transaction History

Jackson Square Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Mar 05, 2021	SELL	$78.07 - $94.43 $24,982 - $30,217	-320 Closed	0 $0
Q3 2020 Nov 17, 2020	SELL	$82.14 - $91.0 $1,314 - $1,456	-16 Reduced 4.76%	320 $28,000
Q2 2020 Aug 18, 2020	BUY	$80.93 - $91.1 $1,780 - $2,004	22 Added 7.01%	336 $29,000
Q1 2020 May 15, 2020	BUY	$70.67 - $99.01 $1,413 - $1,980	20 Added 6.8%	314 $26,000
Q4 2019 May 15, 2020	BUY	$84.35 - $95.37 $24,798 - $28,038	294 New	294 $28,000

1,434

138M

1.48M

1.55M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $235B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Jackson Square Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Jackson Square Capital, LLC with notifications on news.